Qulipta Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Qulipta
R
- Ranexa (ranolazine)
- ranolazine
- Ravicti (glycerol phenylbutyrate)
- Raxar (grepafloxacin)
- RE-PB Hyos Elixir (atropine / hyoscyamine / phenobarbital / scopolamine)
- Recorlev (levoketoconazole)
- Relyvrio (sodium phenylbutyrate / taurursodiol)
- Repan (acetaminophen / butalbital / caffeine)
- repotrectinib
- Rescriptor (delavirdine)
- resmetirom
- Retevmo (selpercatinib)
- Reyataz (atazanavir)
- Rezdiffra (resmetirom)
- Rezlidhia (olutasidenib)
- Rezulin (troglitazone)
- ribociclib
- rifabutin
- Rifadin (rifampin)
- Rifadin IV (rifampin)
- Rifamate (isoniazid / rifampin)
- rifampin
- rifapentine
- Rifater (isoniazid / pyrazinamide / rifampin)
- rifaximin
- Rimactane (rifampin)
- ritonavir
- Robimycin (erythromycin)
- Rozlytrek (entrectinib)
- Rubraca (rucaparib)
- rucaparib
- rufinamide
- Rydapt (midostaurin)
More about Qulipta (atogepant)
- Qulipta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (134)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
